Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer

Citation
Hj. Agteresch et al., Effects of ATP infusion on glucose turnover and gluconeogenesis in patients with advanced non-small-cell lung cancer, CLIN SCI, 98(6), 2000, pp. 689-695
Citations number
51
Categorie Soggetti
Medical Research General Topics
Journal title
CLINICAL SCIENCE
ISSN journal
01435221 → ACNP
Volume
98
Issue
6
Year of publication
2000
Pages
689 - 695
Database
ISI
SICI code
0143-5221(200006)98:6<689:EOAIOG>2.0.ZU;2-#
Abstract
Cancer cachexia is associated with elevated lipolysis, proteolysis and gluc oneogenesis. ATP infusion has been found to significantly inhibit loss of b ody weight, fat mass and fat-free mass in patients with advanced lung cance r. The present study was aimed at exploring the effects of ATP on whole-bod y glucose turnover, alanine turnover and gluconeogenesis from alanine. Twel ve patients with advanced non-small-cell lung cancer (NSCLC) were studied I week before and during 22-24 h of continuous ATP infusion. After an overni ght fast, turnover rates of glucose and alanine, and gluconeogenesis from a lanine, were determined using primed constant infusions of [6,6-H-2(2)]gluc ose and [3-C-13]alanine. Thirteen NSCLC patients and eleven healthy subject s were studied as control groups without ATP infusion. During high-dose ATP infusion (75 mu g.min(-1).kg(-1)), glucose turnover was 0.62+/-0.07 mmol.h (-1).kg(-1), compared with 0.44+/-0.13 mmol.h(-1).kg(-1) at baseline (P = 0 .04). For gluconeogenesis a similar, but non-significant, trend was observe d [baseline, 0.30+/-0.16 mmol.h(-1).kg(-1); during ATP, 0.37+/-0.13 mmol.h( -1).kg(-1) (P = 0.08)]. At lower ATP doses (37-50 mu g.min(-1).kg(-1)) thes e effects were not detected. The relative increase in glucose turnover duri ng ATP infusion compared with baseline showed a significant correlation wit h the ATP dose (r = 0.58, P = 0.02). No change in alanine turnover was obse rved at any ATP dose. The results of this study indicate an increase in glu cose turnover during high-dose ATP infusion compared with baseline levels. During high-dose AIP infusion, glucose turnover was similar to that during low-dose ATP infusion and to that in control NSCLC patients. Between ATP in fusions, however, glucose turnover in patients treated with high-dose ATP w as significantly lower than that in the low-dose and control NSCLC patients (P = 0.04 and P = 0.03 respectively), and similar to that in healthy subje cts. This would suggest that repeated high-dose ATP infusions may inhibit g lucose turnover between infusion periods.